1.High accuracy NURBS interpolation for five-axis machine of table-rotating/spindle-tilting type
Guangkuan WU ; Guang XI ; Hongzhou FAN ; Jiansheng ZHENG
Journal of Pharmaceutical Analysis 2007;19(2):149-153,158
In this paper, the definition of NURBS curve and a speed-controlled interpolation in which the feed rate is automatically adjusted in order to meet the specified chord error limit were discussed. Besides those, a definition of linear interpolation error of post-processed data was proposed, which should be paid more attention to because it will not only reduce quality of the surface but also may cause interference and other unexpected trouble. In order to control the error, a robust algorithm was proposed, which successfully met a desired error limit through interpolating some essential CL data. The excellence of the proposed algorithm, in terms of its reliability and self-adaptiveness, has been proved by simulation results.
2.Impact of increased CD4+ CD25+ FOXP3+ regulatory T cells on tumor recurrence in liver transplantation for hepatocellular carcinoma
Min WU ; Fan HE ; Shengyuan XU ; Zhao DING ; Ming CAI ; Hongzhou LI ; Fanying MENG ; Xiang ZHENG ; Zhishui CHEN
Chinese Journal of Hepatobiliary Surgery 2010;16(7):516-519
Objective To investigate the impact of CD4+ CD25+ FOXP3+ regulatory T(Treg) cells on tumor recurrence in liver transplantation for hepatocellular carcinoma (HCC). Methods Im-munohistochemistry and flow cytometry were used for analysis of the frequency of Treg. Meanwhile,it was compared with that of non-cancer liver transplantation patients. Results The frequency of CD4+CD25+ FOXP3+ regulatory T cells in the blood of HCC liver transplantation was (10. 15 ±1. 00) % , which was significantly higher than that in the normal control group (3. 20±1. 18) %. Cir-culating CD4+ CD25+ FOXP3+ Treg frequency was increased significantly and correlated with the tumor recurrence in the HCC patients. An abundant accumulation of Treg concurrent with significant-ly reduced infiltration of CD8+T cells was found in tumor regions. Conclusion Increased CD4+ D25+FoxP3+ Treg may impair the effectors function of CD8+ T cells, promote the tumor recurrence and re-present a therapeutic target for HCC liver transplantation.
3.The expression changes of TLR4/MyD88/NF-κB signaling pathway in a mouse model of olfactory dysfunction
Qiong FAN ; Xiaoning ZHU ; Hongzhou GE ; Zhijun WANG
Chinese Archives of Otolaryngology-Head and Neck Surgery 2024;31(2):113-116
OBJECTIVE To explore the expression changes of TLR4/MyD88/NF-κB signaling pathways in olfactory disorders.METHODS There were 40 healthy BALB/c mice who were divided into an observation group and a control group,with 20 mice in each group.Detection of Toll-like receptors(TLR4),myeloid differentiation primary response gene 88(MyD88)and nuclear factor kappa B(NF-κB)in mice using quantitative reverse transcription PCR level;Detection of TLR4,MyD88 and NF-κB by Western blot(WB)test protein content;Immunohistochemical detection of the expression of mouse olfactory marker protein(OMP).RESULTS There was no significant difference in foraging time between the two groups of mice before modeling(P>0.05),after modeling,the foraging time of the observation group mice was significantly longer than that of the control group(P<0.05);The relative mRNA expression level of TLR4,MyD88 and NF-κB in the nasal epithelium of mice in the observation group was significantly higher than that of the control group(P<0.05);The protein expression of TLR4,MyD88 and NF-κB in the nasal epithelium of mice in the observation group was significantly higher than that of the control group(P<0.05);The level of OMP protein in the nasal epithelium of the observation group was significantly lower than that of the control group(P<0.05).CONCLUSION Expression reinforcement of TLR4/MyD88/NF-κB signaling pathway in a mouse model of olfactory dysfunction.
4.Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.
Yun TAN ; Feng LIU ; Xiaoguang XU ; Yun LING ; Weijin HUANG ; Zhaoqin ZHU ; Mingquan GUO ; Yixiao LIN ; Ziyu FU ; Dongguo LIANG ; Tengfei ZHANG ; Jian FAN ; Miao XU ; Hongzhou LU ; Saijuan CHEN
Frontiers of Medicine 2020;14(6):746-751
The ongoing pandemic of Coronavirus disease 19 (COVID-19) is caused by a newly discovered β Coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). How long the adaptive immunity triggered by SARS-CoV-2 can last is of critical clinical relevance in assessing the probability of second infection and efficacy of vaccination. Here we examined, using ELISA, the IgG antibodies in serum specimens collected from 17 COVID-19 patients at 6-7 months after diagnosis and the results were compared to those from cases investigated 2 weeks to 2 months post-infection. All samples were positive for IgGs against the S- and N-proteins of SARS-CoV-2. Notably, 14 samples available at 6-7 months post-infection all showed significant neutralizing activities in a pseudovirus assay, with no difference in blocking the cell-entry of the 614D and 614G variants of SARS-CoV-2. Furthermore, in 10 blood samples from cases at 6-7 months post-infection used for memory T-cell tests, we found that interferon γ-producing CD4
Adaptive Immunity/physiology*
;
Adult
;
Aged
;
Antibodies, Neutralizing/blood*
;
COVID-19/immunology*
;
Cohort Studies
;
Female
;
Humans
;
Immunoglobulin G/blood*
;
Male
;
Middle Aged
;
SARS-CoV-2/immunology*
;
T-Lymphocytes/physiology*
;
Time Factors
;
Viral Proteins/immunology*